Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1022 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Pharmacyclics Q4 revenues down

Pharmacyclics’ net loss was $10.96m for the fourth quarter ended 30 June 2011, compared to $6.84, for the same period in 2010. The company’s loss from operations were

Exonhit revenues fall in H1 2011

Exonhit has reported net loss of EUR4.6m for the six months ended 30 June 2011, compared to EUR1.09m for the same period in 2010. For the six months

Avedro VibeX gets FDA orphan drug status

Avedro’s KXL, VibeX and Keraflex are CE marked and are commercially available outside of the US. Currently, the company has filed an additional application for orphan drug designation

Frontage, Spaulding strengthen business in China

Under the agreement, Frontage will combine its drug formulation and Bioanalytical analysis expertise with Spaulding Clinical’s Cardiac Safety and fully-automated Clinical Pharmacology facility. Spaulding Clinical will conduct all

BioData takes over LabLife Software

BioData provides a lab management solution and allows the researchers to monitor materials, projects and experiments easily. LabLife was founded by Melina Fan, Benjie Chen and Kenneth Fan